Suven (SUVENPHAR) | Stock Overview & Key Data

Suven Pharmaceuticals Ltd. | Large-cap | Healthcare

₹1,083.35

-1.24%

Suven vs Sun Pharmaceutical Suven vs Divi's Laboratories Suven vs Torrent Suven vs Cipla Suven vs Mankind Pharma Suven vs NIFTY 50 | Market

Chart Range Statistics Financials Returns Ownership Calculator FAQ

Suven Performance Comparison

Loading chart data...

Performance Summary

Interactive charts require JavaScript. Here's the essential performance data:

Period	Suven	Healthcare Sector	NIFTY 50
1 Week	6.42%	N/A	N/A
1 Month	7.30%	N/A	N/A
3 Months	-9.89%	N/A	N/A
6 Months	0.96%	N/A	N/A
1 Year	32.02%	N/A	N/A
3 Years	132.38%	N/A	N/A
5 Years	270.69%	N/A	N/A

Stock Range

Today's Range

Low: ₹1,072.95 High: ₹1,102.20

on July 18, 2025

52 Week Range

Low: ₹815.05 High: ₹1,360.00

on July 22, 2024

on December 2, 2024

All-Time High: ₹1,360.00 on December 2, 2024

Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights

Key Statistics

Market Cap i INR412.9B

EPS i 10.90

P/E Ratio (TTM) i 99.01

Forward P/E i 57.20

P/B Ratio i 13.88

PEG Ratio i -9.13

Div. Yield i N/A

ROE i 14.38%

Beta i 1.126

Debt to Equity i 1.95

Financial Highlights

Profitability

Gross Margin i 66.67%

Operating Margin i 31.70%

Profit Margin i 26.63%

Returns and Earnings

Return on Assets (TTM) i 8.73%

Return on Equity (TTM) i 14.38%

EBITDA i INR4.3B

Net Income (TTM) i INR2.8B

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i INR41.19

Quarterly Revenue Growth (YoY) i 39.70%

Quarterly Earnings Growth (YoY) i 77.30%

Peer Performance Comparison

Performance comparison table showing returns for peer companies over various time periods
Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Suven SUVENPHAR	412.87B Large-cap	6.42%	7.30%	-9.89%	0.96%	-3.49%	32.02%	132.38%	270.69%
Sun Pharmaceutical SUNPHARMA	3.92T Large-cap	-6.35%	-4.85%	-10.27%	-8.65%	-15.43%	-8.07%	74.63%	200.22%
Divi's Laboratories DIVISLAB	1.63T Large-cap	-7.04%	-10.99%	-0.27%	-0.15%	0.96%	26.95%	64.55%	98.44%
Torrent TORNTPHARM	1.22T Large-cap	-3.88%	7.29%	9.29%	10.38%	5.21%	5.56%	128.85%	24.13%
Cipla CIPLA	1.20T Large-cap	-4.09%	-1.29%	-1.18%	1.27%	0.78%	3.58%	45.16%	93.18%
Mankind Pharma MANKIND	1.08T Large-cap	-1.15%	5.29%	4.33%	0.76%	-11.91%	19.66%	83.31%	83.31%

Ownership & Short Interest

Insider Ownership i 73.19%

Institutional Ownership i 14.76%

Shares Short i N/A

Short Ratio i N/A

Short % of Shares Outstanding i N/A

Average 10-Day Volume i 271K

Average 90-Day Volume i 309K

Suven Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Suven would have performed over time.

Calculator Requires JavaScript

The investment calculator requires JavaScript to perform real-time calculations. Please enable JavaScript for the full experience.

Alternative: Manual Calculation

For historical performance data of Suven, please visit the price history page to analyze returns manually.

Recent Performance Summary:

1 Week: 6.42%
1 Month: 7.30%
3 Months: -9.89%
1 Year: 32.02%

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is SUVENPHAR's 52-week high and low?

In the last 52 weeks, Suven reached a high of ₹1,360.00 (on December 2, 2024) and a low of ₹815.05 (on July 22, 2024).

What is the market cap and P/E ratio for SUVENPHAR?

Curious about Suven's size and valuation? Its market capitalization stands at 412.87B. When it comes to valuation, the P/E ratio (trailing twelve months) is 99.01, and the forward P/E (looking ahead) is 57.20.

Does SUVENPHAR pay dividends? If so, what's the yield?

As for dividends, Suven isn't currently offering a significant yield, or that specific data isn't available right now.

Who are Suven's main competitors or similar companies to consider before investing?

When looking at Suven, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Sun Pharmaceutical SUNPHARMA	3.92T	Healthcare	Drug Manufacturers - Specialty & Generic	-8.07%	74.63%
Divi's Laboratories DIVISLAB	1.63T	Healthcare	Drug Manufacturers - Specialty & Generic	26.95%	64.55%
Torrent TORNTPHARM	1.22T	Healthcare	Drug Manufacturers - Specialty & Generic	5.56%	128.85%
Cipla CIPLA	1.20T	Healthcare	Drug Manufacturers - Specialty & Generic	3.58%	45.16%
Mankind Pharma MANKIND	1.08T	Healthcare	Drug Manufacturers - Specialty & Generic	19.66%	83.31%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Suven Pharmaceuticals Ltd.? (e.g., ROE, Debt/Equity)

To get a sense of Suven's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 14.38%, the Debt to Equity ratio from the most recent quarter is 1.95, and its Gross Profit Margin stands at 66.67%.

What is the recent revenue and earnings growth for SUVENPHAR?

Looking at Suven's growth, its revenue over the trailing twelve months (TTM) was INR10B. Compared to the same quarter last year (YoY), quarterly revenue grew by 39.70%, and quarterly earnings saw a YoY growth of 77.30%.

How much of SUVENPHAR stock is held by insiders and institutions?

Wondering who owns Suven stock? Company insiders (like executives and directors) hold about 73.19% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 14.76%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.